$11.7B ICFR GAP. Pothole? No. Structural failure.
Novo Nordisk’s manufacturing scale-up strategy is built on a #CriticalRisk: The Catalent acquisition systems are excluded from ICFR oversight.
They solved for supply. They failed on data integrity.
A hostile data strategist targets this control gap.
Find your competitor's fatal flaw: Data-Backed Competitive Insight. $6k.